ZYXI - ZYNEX INC


2.245
-0.165   -7.350%

Share volume: 338,773
Last Updated: 04-28-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 1.01%

PREVIOUS CLOSE
CHG
CHG%

$2.41
-0.17
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
81%
Profitability 99%
Dept financing 18%
Liquidity 35%
Performance 89%
Company vs Stock growth
vs
Performance
5 Days
-10.91%
1 Month
2.05%
3 Months
-72.85%
6 Months
-74.83%
1 Year
-80.39%
2 Year
-83.17%
Key data
Stock price
$2.24
P/E Ratio 
85.20
DAY RANGE
$2.08 - $2.40
EPS 
$0.17
52 WEEK RANGE
$1.93 - $12.19
52 WEEK CHANGE
-$79.54
MARKET CAP 
255.083 M
YIELD 
N/A
SHARES OUTSTANDING 
31.743 M
DIVIDEND
$0.10
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
0.79
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$197,438
AVERAGE 30 VOLUME 
$225,383
Company detail
CEO: Thomas Sandgaard
Region: US
Website: zynex.com
Employees: 770
IPO year: 2007
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body.

Recent news
loading